← Eichor
Study identifier: NCT06259292 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

Condition: Hereditary Hemorrhagic Telangiectasia · Arteriovenous Malformations · Telangiectasia  ·  Sponsor: Cure HHT

PhaseN/A
Planned participants10000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

The Comprehensive HHT Outcomes Registry of the United States (CHORUS) is an observational registry of patients diagnosed with Hereditary Hemorrhagic Telangiectasia (HHT). The purpose of this study is to better understand HHT, the symptoms and complications it causes, and the impact the disease has on people's lives. The investigators will collect long-term information about the participant, allowing us to understand how the disease changes over time, and what factors can influence those changes. Ultimately, this should help improve treatments for the disease. Another important goal of the study is to provide a way to contact people to participate in future clinical trials and other research. The registry will be a centralized resource for recruitment for clinical trials. People in the registry will not be obligated to join any of these additional studies, but if interested, can agree to be contacted if they may be eligible for a study. Participants will: * Be asked to provide permission to collect information from their medical records, including things like demographic information, diagnosis information, family history, test results, treatment information, symptoms, complications, lifestyle and other relevant medical information. * Be asked study-related questions by phone or at a clinic visit. * Be asked study-related questions every year after enrollment for up to 10 years or until the study ends. A member of the study team will communicate with participants by phone or…

This description comes directly from the study's public registry record.

Talk to the study team

Nolie E Krock, MSc  ·  410-357-9932  ·  nolie.krock@curehht.org

Cassi Friday, PhD  ·  410-357-9932  ·  cassi.friday@curehht.org

Always discuss trial participation with your own doctor first.

Locations (16)

University of Alabama at BirminghamBirmingham, Alabama, United StatesRecruiting
University of California, Los AngelesLos Angeles, California, United StatesRecruiting
University of California, San FranciscoSan Francisco, California, United StatesRecruiting
University of Colorado, DenverAurora, Colorado, United StatesRecruiting
Yale UniversityNew Haven, Connecticut, United StatesRecruiting
Augusta UniversityAugusta, Georgia, United StatesRecruiting
Massachusetts General HospitalBoston, Massachusetts, United StatesRecruiting
Mayo ClinicRochester, Minnesota, United StatesRecruiting
Washington University School of MedicineSt Louis, Missouri, United StatesRecruiting
Columbia UniversityNew York, New York, United StatesRecruiting
University of North Carolina, Chapel HillChapel Hill, North Carolina, United StatesRecruiting
The Cleveland ClinicCleveland, Ohio, United StatesRecruiting

+ 4 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06259292